BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27696562)

  • 1. Combined antifungal therapy against systemic murine infections by rare Cryptococcus species.
    Thomson P; Mayayo E; López-Fernández L; Guarro J; Capilla J
    Mycoses; 2017 Feb; 60(2):112-117. PubMed ID: 27696562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).
    Silva EG; Paula CR; de Assis Baroni F; Gambale W
    Mycopathologia; 2012 Jun; 173(5-6):445-9. PubMed ID: 22071662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
    Nishikawa H; Fukuda Y; Mitsuyama J; Tashiro M; Tanaka A; Takazono T; Saijo T; Yamamoto K; Nakamura S; Imamura Y; Miyazaki T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Kohno S; Izumikawa K
    J Antimicrob Chemother; 2017 Jun; 72(6):1709-1713. PubMed ID: 28201509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients.
    Kordossis T; Avlami A; Velegraki A; Stefanou I; Georgakopoulos G; Papalambrou C; Legakis NJ
    Med Mycol; 1998 Oct; 36(5):335-9. PubMed ID: 10075504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.
    Calvo E; Pastor FJ; Rodríguez MM; Pujol I; Guarro J
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4074-7. PubMed ID: 20625150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
    Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic humicolus cryptococcosis.
    Shinde SM; Vanarse KS; Pandit AN
    Indian Pediatr; 2004 Nov; 41(11):1162-4. PubMed ID: 15591670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antifungal combination against Cryptococcus spp.
    Reichert-Lima F; Busso-Lopes AF; Lyra L; Peron IH; Taguchi H; Mikami Y; Kamei K; Moretti ML; Schreiber AZ
    Mycoses; 2016 Sep; 59(9):585-93. PubMed ID: 27135278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptococcus laurentii diarrhea post hematopoietic stem cell transplant.
    Bhat V; Vira H; Khattry N; Toshniwal M
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28083955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation.
    Fujioka K; Nagai T; Kinoshita Y; Urushihara M; Hamasaki Y; Shishido S; Kagami S
    CEN Case Rep; 2019 Nov; 8(4):261-265. PubMed ID: 31161376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory effect of voriconazole on the production of proinflammatory cytokines in experimental cryptococcosis in mice with severe combined immunodeficiency.
    Gonçalves Silva E; Marilia de Souza Silva S; Rodrigues Paula C; da Silva Ruiz L; Latercia Tranches Dias A
    J Mycol Med; 2018 Mar; 28(1):106-111. PubMed ID: 29273275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive potential of combination therapy against cryptococcosis employing a novel amphotericin B and fluconazole loaded dual delivery system.
    Khan AA; Alanazi AM; Jabeen M; Khan S; Malik A
    Eur J Pharm Sci; 2018 Jul; 119():171-178. PubMed ID: 29653177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined antifungal therapy in a murine infection by Candida glabrata.
    Mariné M; Serena C; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine reduces amphotericin B deoxycholate nephrotoxicity and improves the outcome of murine cryptococcosis.
    Magalhães TFF; Costa MC; Holanda RA; Ferreira GF; Carvalho VSD; Freitas GJC; Ribeiro NQ; Emídio ECP; Carmo PHF; de Brito CB; de Souza DG; Rocha CEV; Paixão TA; de Resende-Stoianoff MA; Santos DA
    Med Mycol; 2020 Aug; 58(6):835-844. PubMed ID: 31919505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
    Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of pedalitin and amphotericin B against Cryptococcus neoformans by in vitro and in vivo evaluation.
    Sangalli-Leite F; Scorzoni L; Alves de Paula E Silva AC; da Silva JF; de Oliveira HC; de Lacorte Singulani J; Gullo FP; Moraes da Silva R; Regasini LO; Siqueira da Silva DH; da Silva Bolzani V; Fusco-Almeida AM; Soares Mendes-Giannini MJ
    Int J Antimicrob Agents; 2016 Nov; 48(5):504-511. PubMed ID: 27742203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Cryptococcus laurentii infection in an immunocompetent child.
    Molina-Leyva A; Ruiz-Carrascosa JC; Leyva-Garcia A; Husein-Elahmed H
    Int J Infect Dis; 2013 Dec; 17(12):e1232-3. PubMed ID: 23791224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis.
    Santos JRA; Ribeiro NQ; Bastos RW; Holanda RA; Silva LC; Queiroz ER; Santos DA
    Sci Rep; 2017 Jul; 7(1):4661. PubMed ID: 28680034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.
    Barchiesi F; Spreghini E; Schimizzi AM; Maracci M; Giannini D; Carle F; Scalise G
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3312-6. PubMed ID: 15328090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.